Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

By Kirsh V.  

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite

Hormone Replacement Therapy and the Risk of Ovarian Cancer

By Risch H.A.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 115-117

Academic Press

Access to resources Recommend Favorite

Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Aiduk C.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Carcinoma

By Sit A.S.Y.   Modugno F.   Weissfeld J.L.   Berga S.L.   Ness R.B.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 118-123

Academic Press

Access to resources Recommend Favorite

Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

By Porch J.V.  

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite